- Germany
- /
- Capital Markets
- /
- XTRA:B7E
Blue Cap First Half 2024 Earnings: EPS: €0.10 (vs €0.38 loss in 1H 2023)
Blue Cap (ETR:B7E) First Half 2024 Results
Key Financial Results
- Revenue: €129.3m (down 11% from 1H 2023).
- Net income: €452.0k (up from €1.69m loss in 1H 2023).
- Profit margin: 0.3% (up from net loss in 1H 2023).
- EPS: €0.10 (up from €0.38 loss in 1H 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Blue Cap Earnings Insights
Looking ahead, revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 1.4% growth forecast for the Capital Markets industry in Germany.
Performance of the German Capital Markets industry.
The company's share price is broadly unchanged from a week ago.
Risk Analysis
Be aware that Blue Cap is showing 3 warning signs in our investment analysis that you should know about...
Valuation is complex, but we're here to simplify it.
Discover if Blue Cap might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About XTRA:B7E
Blue Cap
A private equity firm specializes in middle market, late stage, mature, turnaround, recapitalization, buyout, special situations, restructuring, corporate carve-out, and growth capital investments.
Reasonable growth potential with adequate balance sheet.